Form 4: Xylem Inc. Executive Meredith Emmerich Reports Stock and Options Award
SEC Form 4 Filing
Meredith Emmerich, SVP & President of AW at Xylem Inc., reports the acquisition of restricted stock units and non-qualified stock options.
Summary
- On March 5, 2025, Meredith Emmerich, SVP & President, AW of Xylem Inc., reported transactions related to Xylem Inc. stock.
- Emmerich acquired 1,060 shares of common stock at $129.67 per share through an award of restricted stock units.
- These restricted stock units will vest in one-third increments on March 5, 2026, March 5, 2027, and March 5, 2028.
- Emmerich also acquired 3,721 non-qualified stock options with an exercise price of $129.67.
- These options are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027, and March 5, 2028.
- Following the reported transactions, Emmerich beneficially owns 4,833 shares of common stock.
- The transactions were reported on Form 4, filed with the SEC on March 6, 2025.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The document reports standard executive compensation, which is generally viewed as a positive sign of alignment between management and shareholders.
Positives
- The award of restricted stock units and stock options suggests confidence in the company's future performance.
- The vesting schedule aligns Emmerich's interests with the long-term success of Xylem Inc.
Future Outlook
The document does not contain explicit forward-looking statements, but the equity awards suggest an expectation of continued growth and value creation at Xylem Inc.
Industry Context
Equity compensation is a common practice in publicly traded companies to align management's interests with those of shareholders. The size and structure of the awards are typical for executives at Emmerich's level.
Comparison to Industry Standards
- Comparing Xylem's equity compensation practices to those of its peers, such as Danaher, Agilent, and Roper Technologies, would provide a more comprehensive understanding of whether the awards are in line with industry standards.
- These companies also utilize stock options and restricted stock units as part of their executive compensation packages.
- Benchmarking the vesting schedules and the number of shares granted relative to company performance metrics would offer further insights.
Stakeholder Impact
- The equity awards align the executive's interests with those of shareholders, potentially driving long-term value creation.
- Employees may view the awards as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 2016-02-24 | Date of the Amended and Restated Xylem 2011 Omnibus Incentive Plan |
| 2025-03-05 | Date of the reported transactions (stock and options award) |
| 2025-03-05 | Date the non-qualified stock options are exercisable |
| 2025-03-06 | Date the Form 4 was signed |
| 2026-03-05 | First vesting date for restricted stock units and stock options |
| 2027-03-05 | Second vesting date for restricted stock units and stock options |
| 2028-03-05 | Final vesting date for restricted stock units and stock options |
| 2035-03-05 | Expiration date for the non-qualified stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.